R. Brookmeyer, D. A. Evans, and L. Hebert, National estimates of the prevalence of Alzheimer's disease in the United States, Alzheimers Dement, vol.7, pp.61-73, 2011.

J. Cummings, G. Lee, and T. Mortsdorf, Alzheimer's disease drug development pipeline, Alzheimers Dement, vol.3, pp.367-84, 2017.

M. S. Albert, S. T. Dekosky, and D. Dickson, The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, vol.7, pp.270-279, 2011.

B. Dubois, H. H. Feldman, and C. Jacova, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria, Lancet Neurol, vol.6, pp.734-780, 2007.

B. Dubois, H. H. Feldman, and C. Jacova, Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria, Lancet Neurol, vol.13, pp.614-643, 2014.

T. Tapiola, I. Alafuzoff, and S. K. Herukka, Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain, Arch Neurol, vol.66, pp.382-391, 2009.

L. S. Honig, A phase 3 Trial of Solanezumab in Mild Dementia due to Alzheimer's Disease, EXPEDITION, vol.3, 2016.

P. Eisele, I. Mcconnell, and T. Loxam, Merck Announces EPOCH Study of Verubecestat for the Treatment of People with Mild to Moderate Alzheimer's Disease to Stop for Lack of, 2017.

J. Sevigny, P. Chiao, and T. Bussière, The antibody aducanumab reduces A? plaques in Alzheimer's disease, Nature, vol.537, pp.50-56, 2016.

. Eisai, Eisai and Biogen announce positive topline results of the final analysis for BAN2401 at 18 months. enews201858, 2018.

L. Duff, F. Develay, A. E. Quetel, and J. , French Alzheimer plan: description of the national Alzheimer information system, J Alzheimers Dis, vol.29, pp.891-902, 2008.

L. Tay, W. S. Lim, and M. Chan, New DSM-V neurocognitive disorders criteria and their impact on diagnostic classifications of mild cognitive impairment and dementia in a memory clinic setting, Am J Geriatr Psychiatry, vol.23, pp.768-79, 2015.

M. F. Folstein, S. E. Folstein, and P. R. Mchugh, Mini-mental state". A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, vol.12, pp.189-98, 1975.

, WHO. International Classification of Diseases

G. M. Mckhann, D. S. Knopman, and H. Chertkow, The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, vol.7, pp.263-272, 2011.

R. C. Petersen, Mild cognitive impairment as a diagnostic entity, J Intern Med, vol.256, pp.183-94, 2004.

T. G. Beach, S. E. Monsell, and L. E. Phillips, Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, J Neuropathol Exp Neurol, vol.71, pp.266-73, 2005.

S. Salloway, R. Sperling, and N. C. Fox, Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease, N Engl J Med, vol.370, pp.322-355, 2014.

R. C. Petersen, P. Aisen, and B. F. Boeve, Mild cognitive impairment due to Alzheimer disease in the community, Ann Neurol, vol.74, pp.199-208, 2013.

E. Grober, H. Buschke, and H. Crystal, Screening for dementia by memory testing, Neurology, vol.38, pp.900-903, 1988.

D. Stefano, F. Epelbaum, S. Coley, and N. , Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial, J Alzheimers Dis, vol.48, pp.793-804, 2015.

M. Sarazin, C. Berr, D. Rotrou, and J. , Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study, Neurology, vol.69, pp.1859-67, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00169640

S. Auriacombe, C. Helmer, and H. Amieva, Validity of the free and cued selective reminding test in predicting dementia: the 3C study, Neurology, vol.74, pp.1760-1767, 2010.

E. Grober, C. Hall, and A. E. Sanders, Free and cued selective reminding distinguishes Alzheimer's disease from vascular dementia, J Am Geriatr Soc, vol.56, pp.944-950, 2008.

E. Grober, A. E. Sanders, and C. Hall, Free and cued selective reminding identifies very mild dementia in primary care, Alzheimer Dis Assoc Disord, vol.24, pp.1-90, 2010.

F. H. Duits, C. E. Teunissen, and F. H. Bouwman, Alzheimer profile": Easily said. but what does it mean?, Alzheimers Dement, 2014.

S. Ostrowitzki, D. Deptula, and L. Thurfjell, Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab, Arch Neurol, vol.69, pp.198-207, 2012.

W. M. Van-der-flier, Y. A. Pijnenburg, and N. Prins, Optimizing patient care and research: the Amsterdam Dementia Cohort, J Alzheimers Dis, vol.41, pp.313-340, 2014.

D. Commenges, P. Joly, and L. Letenneur, Incidence and mortality of Alzheimer's disease or dementia using an illness-death model, Stat Med, vol.23, pp.199-210, 2004.

P. Krolak-salmon, L. Letrilliart, and M. Ceccaldi, Towards a national strategy on the diagnosis of neurocognitive disorders. A shared approach among the French National College of General Practitioners and specialists of neurocognitive disorders

, Presse Med, vol.47, pp.75-83, 2018.

A. Alpérovitch, P. Amouyel, and J. F. Dartigues,

, C R Biol, vol.325, pp.665-72, 2002.

H. Amieva, S. Andrieu, and C. Berr, Alzheimer enjeux scientifiques, médicaux et sociétaux, Inserm publication, pp.431-476, 2007.

M. Löppönen, I. Räihä, and R. Isoaho, Diagnosing cognitive impairment and dementia in primary health care -a more active approach is needed, Age Ageing, vol.32, pp.606-618, 2003.

M. Olafsdóttir, I. Skoog, and J. Marcusson, Detection of dementia in primary care: the Linköping study, Dement Geriatr Cogn Disord, vol.11, pp.223-232, 2000.

D. W. O'connor, P. A. Pollitt, and J. B. Hyde, Do general practitioners miss dementia in elderly patients?, BMJ, vol.297, pp.1107-1117, 1988.

C. Bush, J. Kozak, and T. Elmslie, Screening for cognitive impairment in the elderly, Can Fam Physician, vol.43, pp.1763-1771, 1997.

C. M. Callahan, H. C. Hendrie, and W. M. Tierney, Documentation and evaluation of cognitive impairment in elderly primary care patients, Ann Intern Med, vol.122, pp.422-431, 1995.

E. Rimmer, M. Wojciechowska, and C. Stave, Implications of the Facing Dementia Survey for the general population, patients and caregivers across Europe, Int J Clin Pract Suppl, vol.146, pp.17-24, 2005.

D. Wilkinson, A. Sganga, and C. Stave, Implications of the Facing Dementia Survey for health care professionals across Europe, Int J Clin Pract, vol.59, pp.27-31, 2005.

M. Zins, M. Goldberg, and . Constances, The French CONSTANCES population-based cohort: design, inclusion and follow-up, Eur J Epidemiol, vol.30, pp.1317-1345, 2015.

C. Pradier, C. Sakarovitch, L. Duff, and F. , The mini mental state examination at the time of Alzheimer's disease and related disorders diagnosis, according to age, education, gender and place of residence: a cross-sectional study among the French National Alzheimer database, PLoS One, vol.9, p.103630, 2014.

N. Hoertel, L. Strat, Y. , D. Maricourt, and P. , Are subjects in treatment trials of panic disorder representative of patients in routine clinical practice? Results from a national sample, J Affect Disord, vol.146, pp.383-392, 2013.

E. S. Kim, J. Atlas, and G. Ison, Transforming Clinical Trial Eligibility Criteria to Reflect Practical Clinical Application, Am Soc Clin Oncol Educ Book, vol.35, pp.83-90, 2016.

A. C. Troussière, D. Wallon, and F. Mouton-liger, Who needs cerebrospinal biomarkers? A national survey in clinical practice, J Alzheimers Dis, vol.40, pp.857-61, 2014.

J. Dumurgier, O. Vercruysse, and C. Paquet, Intersite variability of CSF Alzheimer's disease biomarkers in clinical setting, Alzheimers Dement, vol.9, pp.406-419, 2013.

F. Mouton-liger, D. Wallon, and A. C. Troussière, Impact of cerebrospinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric study, J Neurol, vol.261, pp.144-51, 2014.

C. R. Jack, D. A. Bennett, and K. Blennow, Toward a biological definition of Alzheimer's disease, Alzheimers Dement, vol.14, pp.535-62, 2018.

C. R. Jack, D. A. Bennett, and K. Blennow, A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers, Neurology, vol.87, pp.539-586, 2016.

K. Christensen, M. Thinggaard, and A. Oksuzyan, Physical and cognitive functioning of people older than 90 years: a comparison of two Danish cohorts born 10 years apart, Lancet, vol.382, pp.1507-1520, 2013.

K. M. Langa, E. B. Larson, and E. M. Crimmins, A Comparison of the Prevalence of Dementia in the United States in, JAMA internal medicine, 2000.

F. E. Matthews, A. Arthur, and L. E. Barnes, A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II, Lancet, vol.382, pp.1405-1417, 2013.

C. Takizawa, P. L. Thompson, and A. Van-walsem, Epidemiological and economic burden of Alzheimer's disease: a systematic literature review of data across Europe and the United States of America, J Alzheimers Dis, vol.43, pp.1271-84, 2015.

G. D. Rabinovici, C. Gatsonis, and C. Apgar, Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia, JAMA, vol.321, pp.1286-94, 2019.

A. Nakamura, N. Kaneko, and V. L. Villemagne, High performance plasma amyloid-? biomarkers for Alzheimer's disease, Nature, vol.554, pp.249-54, 2018.